While IDH mutation is most characteristic of lower-grade infiltrating gliomas, including astrocytomas and oligodendrogliomas, it was in fact the study of GBM that initially led to the discovery of this recurrently altered gene (9). The gene discussed is IDH2; the disease is glioma.